As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to:www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global:
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China:
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
Medicilon is always keen on continuous exploring on drug development. Recently, Medicilon signed a strategic cooperation agreement with Kuming Pharmaceutical Corporation, Simcere Pharmaceuticals Group and other pharmaceutical companies. This agreement is based on risk-sharing and benefit-sharing principle to utilize the strengths in technology, professional personnel and facilities of both companies. Both companies will achieve complementary advantages and win-win situations.
Besides providing preclinical services to the partner, Medicilon also works with the partner to carry out new drug project collaboration. Both Medicilon and the partner will mutually share the business promotion, new drug development strategy consultation and joint IND filing.